This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Wyeth. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2011
Title: Kim Timothy Arndt: Innovator in Cancer Treatment
Introduction
Kim Timothy Arndt is a notable inventor based in Towaco, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic myelogenous leukemia (CML). With a total of 3 patents to his name, Arndt's work has the potential to impact many lives.
Latest Patents
Among his latest patents, Arndt has developed 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML). These compounds are designed to target specific pathways involved in the disease, showcasing his innovative approach to cancer treatment.
Career Highlights
Arndt is currently employed at Wyeth, a company known for its commitment to advancing healthcare solutions. His work at Wyeth has allowed him to focus on developing new therapeutic options for patients suffering from serious illnesses.
Collaborations
Throughout his career, Arndt has collaborated with talented individuals such as Frank Boschelli and Jennifer M. Golas. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Kim Timothy Arndt's contributions to the field of cancer treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile